NYSE American · MITQHealthcareMedical Instruments & Devices

Moving iMage Technologies financials

$0.5950+3.10%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Jun 30
FY25
Jun 30
FY24
Jun 30
FY23
Jun 30
FY22
Jun 30
Revenue$17.3M$18.1M$20.1M$20.2M$18.4M
Gross profit$5.0M$4.6M$4.7M$5.3M$4.5M
Gross margin29.1%25.2%23.3%26.3%24.3%
Operating income-$498.0K-$1.1M-$1.6M-$2.0M-$1.8M
Net income-$297.0K-$948.0K-$1.4M-$1.8M-$1.3M
Net margin−1.7%−5.2%−6.8%−8.9%−7.3%
Diluted EPS$-0.03$-0.10$-0.13$-0.16$-0.13
EBITDA-$427.0K-$1.0M-$1.5M-$1.9M-$1.6M
Operating cash flow-$2.5M$437.0K-$796.0K$269.0K-$3.4M
Free cash flow-$2.5M$437.0K-$808.0K$254.0K-$3.4M
Diluted shares9.9M9.9M10.5M10.9M10.6M

Balance sheet

Period endJun 30Jun 30Jun 30Jun 30Jun 30
Cash & equivalents$3.2M$5.7M$5.3M$6.6M$2.3M
Short-term investments$0.00$0.00$0.00$0.00$4.4M
Total debt$0.00$0.00$0.00$0.00$0.00
Total assets$8.5M$10.9M$10.5M$13.3M$14.9M
Total liabilities$3.9M$6.0M$4.8M$5.8M$5.4M
Shareholders' equity$4.6M$4.9M$5.7M$7.6M$9.4M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology